Sequential secures £2.6m in funding led by Sparkfood and Corundum Systems Biology for non-invasive testing of skin health ingredients

Sequential develops genomic testing from non-invasive human clinical samples to analyse how ingredients and products affect microbial and host biomarkers on the skin. Its testing platform converts biological data into insights for consumer, biotech and pharmaceutical companies developing personal care and health products.